VANCOUVER, British Columbia — February 24, 2026 — Leads & Copy —
Cannabix Technologies Inc. has announced the closing of its non-brokered private placement financing. The offering involved the issuance of 1,400,000 units at a price of CDN$0.50 per unit, resulting in gross proceeds of CDN$700,000.
Each unit comprises one common share of the company and one non-transferable common share purchase warrant. Warrants can be exercised into one share at CDN$0.65 per share for 24 months from the issuance date. The warrants are subject to an acceleration clause: If the closing price of shares on the Canadian Securities Exchange reaches or exceeds CDN$0.75 for 10 consecutive trading days, the company can accelerate the warrant expiry date by providing notice via news release. In such a case, the warrants will expire 30 calendar days after the announcement of the Triggering Event.
The company intends to use the net proceeds from the offering to fund manufacturing inventory and labor, cover general and administrative expenses (including investor relations), and for unallocated working capital.
The units were offered for sale to purchasers resident in Canada (excluding Quebec), and outside the United States, under National Instrument 45-106 – Prospectus Exemptions, specifically the listed issuer financing exemption. Units issued under this exemption are not subject to resale restrictions under Canadian securities legislation.
An offering document dated February 6, 2026, providing further details on the offering, is accessible on SEDAR+ and the company’s website.
The CEO of Cannabix Technologies acquired 126,000 units in the offering, which is considered a “related party transaction” under Multilateral Instrument 61-101. The company has determined that the CEO’s participation is exempt from formal valuation and minority shareholder approval requirements, as the value of the units acquired does not exceed 25% of the company’s market capitalization. The company is filing a material change report related to the offering less than 21 days before completion, which they say is necessary to complete the offering quickly.
Cannabix Technologies paid CDN$7,360 in cash as finder’s fees and issued 14,720 finder’s warrants. Each warrant allows the holder to acquire one share at CDN$0.65 for 24 months from the issuance date, subject to the acceleration clause.
An investor of the company held a contractual participation right in equity financings until May 15, 2026, however, Cannabix Technologies received a waiver from the investor, who has declined to exercise their participation right in connection with the offering.
The company has stated that this press release does not constitute an offer to sell or a solicitation of an offer to buy securities in the United States. The securities have not been registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption.
We seek Safe Harbor.
Cannabix Technologies Inc. is overseen by its Board of Directors with Rav Mlait as CEO, more information is available from the company at info@cannabixtechnologies.com.
The CSE has not reviewed this release and does not accept responsibility for its accuracy or adequacy.
This press release contains forward-looking statements, which are subject to risks and uncertainties. Actual results may differ from those anticipated due to various factors. The company disclaims any obligation to update these statements, except as required by law.
Source: Cannabix Technologies Inc.
